Literature DB >> 26379969

Escopoletin treatment induces apoptosis and arrests cell cycle at G0/G1 phase in the oral squamous cancer cell lines.

Zhuo Wang1, Hua-Yan Guo1, Yuan-Liang Huang1.   

Abstract

This study was aimed to investigate the antiproliferative effect of escopoletin on CAL 27 and CAL 33 oral squamous cancer cell lines. MTT assay and flow cytometry were used for the analysis of escopoletin effect on cell viability and apoptosis, respectively. Western blot analysis was used for the examination of cyclin and cyclin-dependent kinase expression after treatment of CAL 33 cells with escopoletin. The results showed a marked decrease in the viability of CAL 27 and CAL 33 cell lines after 48 h of escopoletin treatment. Treatment of CAL 33 cells with escopoletin led to the induction of apoptosis and arrest of cell cycle at G0/G1 phase. In the cells treated with escopoletin cyclin D1 and E expression was reduced and CDK1 expression was inactivated. The above findings suggest that escopoletin exhibits inhibitory effect on the oral squamous cancer through induction of apoptosis and arrest of cell cycle. Therefore escopoletin can be a promising candidate for the prevention of oral squamous cancer.

Entities:  

Keywords:  Antiproliferative; apoptosis; cyclins; escopoletin; squamous

Year:  2015        PMID: 26379969      PMCID: PMC4565352     

Source DB:  PubMed          Journal:  Int J Clin Exp Med        ISSN: 1940-5901


  24 in total

Review 1.  Living with oral cancer: epidemiology with particular reference to prevalence and life-style changes that influence survival.

Authors:  Saman Warnakulasuriya
Journal:  Oral Oncol       Date:  2010-04-18       Impact factor: 5.337

2.  Tongue and tonsil carcinoma: increasing trends in the U.S. population ages 20-44 years.

Authors:  Caroline H Shiboski; Brian L Schmidt; Richard C K Jordan
Journal:  Cancer       Date:  2005-05-01       Impact factor: 6.860

3.  The oral cancer epidemic in central and eastern Europe.

Authors:  Werner Garavello; Paola Bertuccio; Fabio Levi; Franca Lucchini; Cristina Bosetti; Matteo Malvezzi; Eva Negri; Carlo La Vecchia
Journal:  Int J Cancer       Date:  2010-07-01       Impact factor: 7.396

4.  Sequential chemoradiotherapy with docetaxel, cisplatin, and 5-fluorouracil in patients with locally advanced head and neck cancer.

Authors:  J Janinis; M Papadakou; G Panagos; A Panousaki; V Georgoulias; D Hatzidaki; D Lefantzis; G Dokianakis
Journal:  Am J Clin Oncol       Date:  2001-06       Impact factor: 2.339

Review 5.  Apigenin and cancer chemoprevention: progress, potential and promise (review).

Authors:  Deendayal Patel; Sanjeev Shukla; Sanjay Gupta
Journal:  Int J Oncol       Date:  2007-01       Impact factor: 5.650

Review 6.  Flavonoids: old and new aspects of a class of natural therapeutic drugs.

Authors:  G Di Carlo; N Mascolo; A A Izzo; F Capasso
Journal:  Life Sci       Date:  1999       Impact factor: 5.037

7.  Cancer statistics, 2010.

Authors:  Ahmedin Jemal; Rebecca Siegel; Jiaquan Xu; Elizabeth Ward
Journal:  CA Cancer J Clin       Date:  2010-07-07       Impact factor: 508.702

8.  Apigenin induces apoptosis and impairs head and neck carcinomas EGFR/ErbB2 signaling.

Authors:  Laura Masuelli; Laura Marzocchella; Alessandro Quaranta; Camilla Palumbo; Giorgio Pompa; Valerio Izzi; Antonella Canini; Andrea Modesti; Fabio Galvano; Roberto Bei
Journal:  Front Biosci (Landmark Ed)       Date:  2011-01-01

9.  Synergistic effects of apigenin and paclitaxel on apoptosis of cancer cells.

Authors:  Yimiao Xu; Yinqiang Xin; Ying Diao; Changyan Lu; Jin Fu; Lan Luo; Zhimin Yin
Journal:  PLoS One       Date:  2011-12-21       Impact factor: 3.240

10.  Apigenin Induces Apoptosis through a Mitochondria/Caspase-Pathway in Human Breast Cancer MDA-MB-453 Cells.

Authors:  Eun Jeong Choi; Gun-Hee Kim
Journal:  J Clin Biochem Nutr       Date:  2009-04-25       Impact factor: 3.114

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.